What is Merck & Co.'s ohtuvayre — intangible assets?

Merck & Co. (MRK) reported ohtuvayre — intangible assets of $11.80B in Q4 2025.

What does ohtuvayre — intangible assets mean?

The total accounting value of intellectual property and patents tied to the Ohtuvayre product line.

Discontinued — last reported Q4 '25

Products & Services · Intangible assets

Ohtuvayre — Intangible assets

Analysis

StatementSegment

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ4 2025

Last reportedQ4 2025

Rolls up toIntangible assets — net

How to read this metric

An increase typically reflects recent acquisitions or capitalization of development costs, while a decrease indicates ongoing amortization or potential impairment charges.

Detailed definition

This metric represents the net book value of capitalized intangible assets specifically associated with the Ohtuvayre pr...

Peer comparison

Comparable to capitalized product rights or acquired intangible assets reported by other pharmaceutical companies for specific drug franchises.

Metric ID: mrk_segment_ohtuvayre_intangible_assets

Historical Data

1 periods

	Q4 '25
Value	$11.80B

Similar Metrics at Other Companies

AmgenAMGN View metric

AbbVieABBV View metric

Frequently Asked Questions

What is Merck & Co.'s ohtuvayre — intangible assets?: Merck & Co. (MRK) reported ohtuvayre — intangible assets of $11.80B in Q4 2025.
What does ohtuvayre — intangible assets mean?: The total accounting value of intellectual property and patents tied to the Ohtuvayre product line.